Currently out of the existing stock ratings of Craig Wong-Pan, 5 are a SELL (15.15%), 19 are a HOLD (57.58%), 9 are a BUY (27.27%).

Craig Wong-Pan

Work Performance Price Targets & Ratings Chart

Analyst Craig Wong-Pan, currently employed at RBC, carries an average stock price target met ratio of 78.13% that have a potential upside of 23.4% achieved within 298 days.

Craig Wong-Pan’s has documented 65 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RMD, ResMed at 15-Sep-2026.

Wall Street Analyst Craig Wong-Pan

Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 4/10/2024. The price target of $187 was fulfilled within 1 day with a profit of $2.24 (1.18%) receiving and performance score of 11.84.

Average potential price target upside

RMD ResMed

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 07-Aug-2026

$262

$43.11 (19.69%)

$244

22 days ago
(15-Sep-2026)

25/32 (78.13%)

$32.56 (14.19%)

298

Buy Since 06-Feb-2024

$267

$48.11 (21.98%)

$255

1 months 6 days ago
(31-Aug-2026)

6/12 (50%)

$26.9 (11.20%)

152

Hold Since 19-Aug-2026

$230

$8 (3.60%)

1 months 18 days ago
(19-Aug-2026)

1/1 (100%)

$0.01 (0.00%)

2

Hold Since 13-Oct-2025

$215

$-3.89 (-1.78%)

$225

2 months ago
(07-Aug-2026)

4/5 (80%)

$3.67 (1.74%)

40

Hold Since 10-Jan-2025

$225

$6.11 (2.79%)

$275

2 months ago
(07-Aug-2026)

5/6 (83.33%)

$13.67 (6.47%)

51

Show more analysts

Please expand the browser size to see the chart

Which stock is Craig Wong-Pan most bullish on?

Potential upside of $43.11 has been obtained for RMD (RESMED)

What Year was the first public recommendation made by Craig Wong-Pan?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?